MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
Liqiang Chen, Qingli Zhu, Lingwei Lu, Yanshan Liu
Abstract
. These observations indicate that miR-132 may be a suitable therapeutic target for the treatment of OSCC.
Topics & Concepts
CisplatinDownregulation and upregulationCancer researchmicroRNACell growthApoptosisCell cultureBiologyCellCell migrationChemotherapyGeneBiochemistryGeneticsMicroRNA in disease regulationCancer-related molecular mechanisms researchCircular RNAs in diseases